Easy Bio이지바이오
353810 · KOSDAQ · ₩353810 · 이지바이오
₩5,350▼ ₩50 (0.93%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 26.4% | 25.4% | 25.6% | 31.5% | 31.4% | 31.4% |
| Operating margin | 10.1% | 9.4% | 8.4% | 12.5% | 10.4% | 13.0% |
| Net margin | 7.6% | 5.8% | 5.1% | 9.4% | 5.9% | 8.4% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +10.1% | +24.1% | +132.4% | +6.3% | +20.2% | — |
| Operating income growth | +18.1% | +38.9% | +57.0% | +27.7% | −3.7% | — |
| Net income growth | +43.4% | +41.7% | +26.1% | +70.2% | −16.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 34.0% | 29.1% | 26.7% | 27.6% | 19.7% | 25.3% |
| Return on assets | 10.1% | 8.5% | 7.5% | 9.8% | 6.8% | 9.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 192.2% | 188.4% | 305.4% | 160.0% | 198.8% | 159.2% |
| Net debt to equity | 96.4% | 80.3% | 144.9% | 33.6% | 78.0% | 64.8% |
| Current ratio | 123.5% | 134.9% | 171.4% | 166.3% | 126.2% | 102.6% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Easy Bio / 이지바이오 / 353810 / KRX:353810
Source: KRX statistical information